Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

By RheumNow FEATURING John J. Cush

467 views

January 13, 2021

1 Comment

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Feat. A. Brown

15:45

Daniel Arkfeld

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

24:23

NYU Langone

How RA Associated HLA-DR Molecules Contribute to the Development of …

Feat. J. Roudier

45:17

ARTHROS

Update in the Understanding and Management of Lupus

Feat. M. Petri

52:53

University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith

17:39

Saakshi Khattri

Dermatologic Manifestations in Rheumatic Diseases

21:41

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

Feat. S. Metyas

10:53

RheumNow

Diagnosing Neuropsychiatric Lupus

Feat. J. Cush

21:34

CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni

14:09

Keck School of Medicine of USC

Vitamin D Deficiency

Feat. V. Gevorgyan

58:00

West Virginia State Rheumatology Society

2022 Updates on the Management of Lupus Nephritis

Feat. M. Petri

11:54

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Embedding Treat to Target Principle…

Feat. S. Dowell

43:45

University of Colorado Department of Medicine

Advances in Rheumatoid Arthritis Associated Interstitial Lung Disease

Feat. J. Lee

23:59

RheumNow

Methotrexate Use: 50 Year Perspective

Feat. J. Kremer

05:58

Cleveland Clinic Rheumatology

Ever-Evolving Lupus Case & Cytopenias in SLE

Feat. E. Littlejohn

25:25

Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert

34:08

Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells

19:54

Michelle Petri

Challenging Cases in Neuropsychiatric Lupus

25:23

Hospital for Special Surgery

Health Disparities in SLE

Feat. J. Yazdany

40:59

UCSF School of Medicine

Login

Login

Join VuMedi

Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

Related Content